Cargando…
Clinical features and outcomes of COVID-19 despite SARS-CoV-2 vaccination in people with multiple sclerosis
BACKGROUND: Several studies have demonstrated reduced serological response to vaccines in patients treated with anti-CD20 agents. However, limited data exist surrounding the clinical effect of disease modifying therapy (DMT) use on vaccine efficacy. OBJECTIVES: To investigate breakthrough coronaviru...
Autores principales: | Rose, Deja R, Mahadeen, Ahmad Z, Carlson, Alise K, Planchon, Sarah M, Sedlak, Jennifer, Husak, Scott, Bermel, Robert A, Cohen, Jeffrey A, Moss, Brandon P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8673876/ https://www.ncbi.nlm.nih.gov/pubmed/34925875 http://dx.doi.org/10.1177/20552173211057110 |
Ejemplares similares
-
The relationship between cognition, education, and employment in multiple sclerosis patients
por: Conway, Devon S, et al.
Publicado: (2022) -
Obtaining Patient Priorities in a Multiple Sclerosis Comprehensive Care Center: Beyond Patient-Reported Outcomes
por: Miller, Deborah M, et al.
Publicado: (2019) -
Multiple sclerosis management during the COVID-19 pandemic
por: Moss, Brandon P, et al.
Publicado: (2020) -
Outcome Measures in Multiple Sclerosis
por: Bermel, Robert, et al.
Publicado: (2014) -
Serum neurofilament light chain concentration in a phase 1/2
trial of autologous mesenchymal stem cell
transplantation
por: Baldassari, Laura E, et al.
Publicado: (2019)